AKRO β€” AKERO THERAPEUTICS INC

Ownership history in Aberdeen Group plc  Β·  8 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.04% (2025 Q3)
πŸ“Š Avg. % of fund
0.02%
πŸ“… First filed
2023 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
8
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 8 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 502,913 +111,313 +28.4% 0.04% $23.9M β€”
2025 Q2 REDUCED 391,600 -15,100 -3.7% 0.04% $20.9M β€”
2025 Q1 ADDED 406,700 +136,918 +50.8% 0.03% $16.5M β€”
2024 Q4 ADDED 269,782 +146,424 +118.7% 0.01% $7.5M β€”
2024 Q3 REDUCED 123,358 -75,879 -38.1% 0.01% $3.5M β€”
2024 Q2 UNCHANGED 199,237 β€” 0% 0.01% $4.7M β€”
2024 Q1 ADDED 199,237 +127,695 +178.5% 0.01% $5.0M β€”
2023 Q4 INITIATED 71,542 β€” β€” 0.00% $1.7M β€”

🏒 Other funds also holding AKRO

As of 2025 Q4 β€” sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to Aberdeen Group plc Holdings